Announcement under Regulation 30 (LODR)-Allotment

Summary by 6ix AI

Eiko Lifesciences Limited has announced the allotment of equity shares following the conversion of warrants into equity shares, as per regulatory requirements. The Board approved the conversion of a specified number of warrants into equity shares at a defined issue price, which has resulted in an increase in the company's paid-up equity share capital. Details regarding the allotment are provided in an annexure accompanying the announcement.

Written by 6ix AI from the company’s filing. How 6ix writes summaries